These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6183945)

  • 21. Direct proof of autoreactive T-lymphocytes in experimental allergical encephalomyelitis (EAE).
    Beer M; von Specht BU; Permanetter W; Brendel W
    Acta Neuropathol Suppl; 1981; 7():169-72. PubMed ID: 6164238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The spinal cord protein (SCP): appraisal of physiological and immunological hypotheses of anti-encephalitogenic action.
    MacPherson CF
    Immunochemistry; 1978 Nov; 15(10-11):767-75. PubMed ID: 85602
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-myelin basic protein antibody in experimental allergic optic neuritis and encephalomyelitis.
    Robin JB; Phillips TM; Rao NA
    Ophthalmic Res; 1985; 17(3):174-80. PubMed ID: 2409498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial characterization of the human anti-encephalitogenic protein: isolation from spinal cord and spinal nerves.
    Weir KG; MacPherson CF
    Biochim Biophys Acta; 1978 Feb; 532(2):232-41. PubMed ID: 75025
    [No Abstract]   [Full Text] [Related]  

  • 25. Response of rat encephalitogenic T cells to synthetic peptides of guinea pig myelin basic protein.
    Vandenbark AA; Hashim G; Offner H
    Ann N Y Acad Sci; 1988; 540():337-9. PubMed ID: 2462807
    [No Abstract]   [Full Text] [Related]  

  • 26. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice.
    Mokhtarian F; McFarlin DE; Raine CS
    Nature; 1984 May 24-30; 309(5966):356-8. PubMed ID: 6203039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allergic encephalomyelitis: modification of the response by synthetic membrane structures containing bovine myelin basic protein and cerebroside.
    Brostoff SW; Powers JM
    Brain Res; 1975 Jul; 93(1):175-81. PubMed ID: 49214
    [No Abstract]   [Full Text] [Related]  

  • 28. Autoimmune reactions against myelin basic protein induced by corona and measles viruses.
    ter Meulen V
    Ann N Y Acad Sci; 1988; 540(1):202-9. PubMed ID: 2462802
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of autoimmune diseases by oral tolerance to autoantigens.
    Weiner HL; Miller A; Khoury SJ; Zhang ZJ; al-Sabbagh A; Brod SA; Lider O; Higgins P; Sobel R; Matsui M
    Adv Exp Med Biol; 1995; 371B():1217-23. PubMed ID: 7502787
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunological cross-reactivity between acid extracts of myelin, liver and neoplastic tissues: studies in immunized guinea-pigs.
    Flavell DJ; Goepel J; Wilson AP; Potter CW
    Br J Cancer; 1979 Sep; 40(3):424-36. PubMed ID: 92328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of experimentally induced autoimmunity in rats by biotin deficiency.
    Rabin BS
    J Nutr; 1983 Nov; 113(11):2316-22. PubMed ID: 6195318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of "original antigenic sin" in autoimmunity provides an unforeseen platform for immune therapy.
    Steinman L
    J Exp Med; 1999 Apr; 189(7):1021-4. PubMed ID: 10190892
    [No Abstract]   [Full Text] [Related]  

  • 33. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis.
    Critchfield JM; Racke MK; Zúñiga-Pflücker JC; Cannella B; Raine CS; Goverman J; Lenardo MJ
    Science; 1994 Feb; 263(5150):1139-43. PubMed ID: 7509084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune encephalomyelitis ameliorated by AMPA antagonists.
    Smith T; Groom A; Zhu B; Turski L
    Nat Med; 2000 Jan; 6(1):62-6. PubMed ID: 10613825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis.
    Weinberg AD; Lemon M; Jones AJ; Vainiene M; Celnik B; Buenafe AC; Culbertson N; Bakke A; Vandenbark AA; Offner H
    J Neurosci Res; 1996 Jan; 43(1):42-9. PubMed ID: 8838572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.
    Lohse AW; Mor F; Karin N; Cohen IR
    Science; 1989 May; 244(4906):820-2. PubMed ID: 2471264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: rapid induction of Th1-type cytokines and inducible nitric oxide synthase.
    Weishaupt A; Jander S; Brück W; Kuhlmann T; Stienekemeier M; Hartung T; Toyka KV; Stoll G; Gold R
    J Immunol; 2000 Dec; 165(12):7157-63. PubMed ID: 11120847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimum structural requirements for encephalitogen and for adjuvant in the induction of experimental allergic encephalomyelitis.
    Nagai Y; Akiyama K; Suzuki K; Kotani S; Watanabe Y; Shimono T; Shiba T; Kusumoto S; Ikuta F; Takeda S
    Cell Immunol; 1978 Jan; 35(1):158-67. PubMed ID: 74289
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis.
    Lolli F; Liuzzi GM; Vergelli M; Massacesi L; Ballerini C; Amaducci L; Riccio P
    J Neuroimmunol; 1993 Apr; 44(1):69-75. PubMed ID: 7684401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of water-soluble adjuvant fraction from "Mycobacterium smegmatis" with encephalitogenic basic protein to induce autoimmune experimental allergic encephalomyelitis in guinea pigs (author's transl)].
    Lebar R; Voisin GA
    Ann Immunol (Paris); 1974 Nov; 125(6):911-6. PubMed ID: 4143099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.